Peter Bright-Asare

700 total citations
16 papers, 558 citations indexed

About

Peter Bright-Asare is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peter Bright-Asare has authored 16 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Peter Bright-Asare's work include Helicobacter pylori-related gastroenterology studies (8 papers), Gastroesophageal reflux and treatments (3 papers) and Eosinophilic Esophagitis (3 papers). Peter Bright-Asare is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (8 papers), Gastroesophageal reflux and treatments (3 papers) and Eosinophilic Esophagitis (3 papers). Peter Bright-Asare collaborates with scholars based in United States, United Kingdom and Canada. Peter Bright-Asare's co-authors include Henry J. Binder, Douglas L. Brand, Stephen J. Sontag, Walter M. Roufail, Gordon L. Kauffman, Vincent A. DeLuca, Justin W. Griffin, Malcolm M. Berenson, Richard A. Kozarek and Quincy‐Robyn Young and has published in prestigious journals such as Gastroenterology, Cancer and The American Journal of Medicine.

In The Last Decade

Peter Bright-Asare

16 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bright-Asare United States 7 217 147 144 99 74 16 558
I. G. M. Cleator Canada 10 337 1.6× 117 0.8× 142 1.0× 55 0.6× 11 0.1× 32 538
G. P. Vanberge-Henegouwen Netherlands 18 446 2.1× 458 3.1× 124 0.9× 58 0.6× 34 0.5× 25 942
Roger G. Berlin United States 12 161 0.7× 135 0.9× 21 0.1× 46 0.5× 24 0.3× 21 352
H Lagerlöf Sweden 12 199 0.9× 72 0.5× 28 0.2× 44 0.4× 108 1.5× 24 489
Allan McNair Denmark 14 114 0.5× 25 0.2× 34 0.2× 39 0.4× 144 1.9× 31 442
Lara Ribeiro‐Parenti France 15 382 1.8× 46 0.3× 111 0.8× 73 0.7× 36 0.5× 30 581
G C Fenn United Kingdom 9 183 0.8× 86 0.6× 39 0.3× 51 0.5× 44 0.6× 14 437
H. J. Balks Germany 10 140 0.6× 22 0.1× 143 1.0× 65 0.7× 23 0.3× 11 526
Cengiz Pata Türkiye 13 227 1.0× 247 1.7× 49 0.3× 86 0.9× 11 0.1× 32 598
Elizabeth Rock United States 9 316 1.5× 237 1.6× 62 0.4× 17 0.2× 12 0.2× 9 673

Countries citing papers authored by Peter Bright-Asare

Since Specialization
Citations

This map shows the geographic impact of Peter Bright-Asare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bright-Asare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bright-Asare more than expected).

Fields of papers citing papers by Peter Bright-Asare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bright-Asare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bright-Asare. The network helps show where Peter Bright-Asare may publish in the future.

Co-authorship network of co-authors of Peter Bright-Asare

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bright-Asare. A scholar is included among the top collaborators of Peter Bright-Asare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bright-Asare. Peter Bright-Asare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bright-Asare, Peter, et al.. (1992). A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.. PubMed. 87(7). 847–53. 4 indexed citations
2.
Bright-Asare, Peter, et al.. (1988). Prostaglandine, H2-Rezeptorantagonisten und Ulkuskrankheit. Drugs. 35(Supplement 3). 1–9. 6 indexed citations
3.
Bright-Asare, Peter, et al.. (1987). Depletion of endogenous histamine abolishes the gastric secretagogue effect of carbachol. Gastroenterology. 92(6). 2058–2058. 1 indexed citations
4.
Bright-Asare, Peter, et al.. (1987). Endogenous histamine may mediate gastric acid secretagogue effects of gastrin and cholineric receptor agonists. Gastroenterology. 92(6). 2058–2058. 1 indexed citations
5.
Hirschowitz, B.I., Malcolm M. Berenson, Jesse M. Berkowitz, et al.. (1986). A Multicenter Study of Ranitidine Treatment of Duodenal Ulcers in the United States. Journal of Clinical Gastroenterology. 8(3 Part 2). 359–366. 14 indexed citations
6.
Bright-Asare, Peter. (1986). Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue. The American Journal of Medicine. 81(2). 64–68. 25 indexed citations
7.
Bright-Asare, Peter, et al.. (1986). Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. Digestive Diseases and Sciences. 31(S2). 63S–67S. 38 indexed citations
8.
Hirschowitz, Basil I., Vincent A. DeLuca, David Graham, et al.. (1986). Treatment of Benign Chronic Gastric Ulcer with Ranitidine. Journal of Clinical Gastroenterology. 8(3 Part 2). 371–376. 4 indexed citations
9.
Bright-Asare, Peter, et al.. (1985). Prostaglandins and chemotherapy-induced ulcers in dogs. Digestive Diseases and Sciences. 30(S11). 201S–203S. 4 indexed citations
10.
Bright-Asare, Peter, et al.. (1984). Prostaglandins, gastroduodenal ulcer and hemorrhagic gastritis.. PubMed. 2(2-3). 101–10. 4 indexed citations
11.
Bright-Asare, Peter & Gordon L. Kauffman. (1984). 16-16 dimethyl prostaglandin E2 reduces 5-fluorouracil-induced and mitomycin C-induced gastric mucosal injury in the dog. Cancer. 54(1). 28–31. 4 indexed citations
12.
Hoffman, Arthur, Quincy‐Robyn Young, Peter Bright-Asare, et al.. (1983). Early Detection of Bowel Cancer at an Urban Public Hospital: Demonstration Project. CA A Cancer Journal for Clinicians. 33(6). 344–358. 15 indexed citations
13.
Bright-Asare, Peter, et al.. (1980). Cimetidine, Metoclopramide, or Placebo in the Treatment of Symptomatic Gastroesophageal Reflux. Journal of Clinical Gastroenterology. 2(2). 149–156. 82 indexed citations
14.
Bright-Asare, Peter & Henry J. Binder. (1973). Stimulation of Colonic Secretion of Water and Electrolytes by Hydroxy Fatty Acids. Gastroenterology. 64(1). 81–88. 160 indexed citations
15.
16.
Bright-Asare, Peter. (1967). Thyrotoxicosis and the heart. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. G. M. Cleator Breakdown of academic impact, for papers by G. P. Vanberge-Henegouwen Breakdown of academic impact, for papers by Roger G. Berlin Breakdown of academic impact, for papers by H Lagerlöf Breakdown of academic impact, for papers by Allan McNair Breakdown of academic impact, for papers by Lara Ribeiro‐Parenti Breakdown of academic impact, for papers by G C Fenn Breakdown of academic impact, for papers by H. J. Balks Breakdown of academic impact, for papers by Cengiz Pata Breakdown of academic impact, for papers by Elizabeth Rock
Rankless by CCL
2026